FDA Inspection
Janssen Pharmaceutica, N.V.Janssen Pharmaceutica, N.V. – FDA Inspection, Jun 12, 2018
Record Details
This FDA Inspection record concerns Janssen Pharmaceutica, N.V., with an inspection on June 12, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e54555d0-cf11-4c2b-95a8-8722099e9c5f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1055920
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Janssen Pharmaceutica, N.V.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | Not classified | Office of Inspections and Investigations | |
| September 5, 2025 | Not classified | Office of Inspections and Investigations | |
| May 12, 2025 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 2, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 1, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Janssen Pharmaceutica, N.V.
- FDA Inspection 1290376 - 2025-11-21
- FDA Inspection 1270321 - 2025-09-05
- FDA Inspection 1296030 - 2025-05-12
- FDA Inspection 1203728 - 2021-07-02
- FDA Inspection 964766 - 2016-03-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.